These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26398412)

  • 1. Risk stratification by cardiac magnetic resonance imaging after ST-elevation myocardial infarction.
    Reinstadler SJ; Thiele H; Eitel I
    Curr Opin Cardiol; 2015 Nov; 30(6):681-9. PubMed ID: 26398412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction.
    Eitel I; de Waha S; Wöhrle J; Fuernau G; Lurz P; Pauschinger M; Desch S; Schuler G; Thiele H
    J Am Coll Cardiol; 2014 Sep; 64(12):1217-26. PubMed ID: 25236513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular magnetic resonance-derived intramyocardial hemorrhage after STEMI: Influence on long-term prognosis, adverse left ventricular remodeling and relationship with microvascular obstruction.
    Husser O; Monmeneu JV; Sanchis J; Nunez J; Lopez-Lereu MP; Bonanad C; Chaustre F; Gomez C; Bosch MJ; Hinarejos R; Chorro FJ; Riegger GA; Llacer A; Bodi V
    Int J Cardiol; 2013 Sep; 167(5):2047-54. PubMed ID: 22682700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six-Year Prognostic Value of Microvascular Obstruction After Reperfused ST-Elevation Myocardial Infarction as Assessed by Contrast-Enhanced Cardiovascular Magnetic Resonance.
    Regenfus M; Schlundt C; Krähner R; Schönegger C; Adler W; Ludwig J; Daniel WG; Schmid M
    Am J Cardiol; 2015 Oct; 116(7):1022-7. PubMed ID: 26260397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study.
    Lønborg J; Vejlstrup N; Kelbæk H; Holmvang L; Jørgensen E; Helqvist S; Saunamäki K; Ahtarovski KA; Bøtker HE; Kim WY; Clemmensen P; Engstrøm T
    Eur Heart J Cardiovasc Imaging; 2013 Apr; 14(4):387-95. PubMed ID: 23178864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction.
    Bodi V; Sanchis J; Nunez J; Mainar L; Lopez-Lereu MP; Monmeneu JV; Rumiz E; Chaustre F; Trapero I; Husser O; Forteza MJ; Chorro FJ; Llacer A
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):835-42. PubMed ID: 19608133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction.
    Rommel KP; Baum A; Mende M; Desch S; Gutberlet M; Schuler G; Thiele H; Eitel I
    Heart; 2014 Aug; 100(16):1257-63. PubMed ID: 25049315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
    Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of RV dysfunction and myocardial infarction assessed by CMR are independent outcome predictors early after STEMI treated with primary angioplasty.
    Miszalski-Jamka T; Klimeczek P; Tomala M; Krupiński M; Zawadowski G; Noelting J; Lada M; Sip K; Banyś R; Mazur W; Kereiakes DJ; Zmudka K; Pasowicz M
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1237-46. PubMed ID: 21163452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of long-term statin pretreatment on myocardial damage in ST elevation myocardial infarction (from the AIDA STEMI CMR Substudy).
    Fuernau G; Eitel I; Wöhrle J; Kerber S; Lauer B; Pauschinger M; Schwab J; Birkemeyer R; Pfeiffer S; Mende M; Brosteanu O; Neuhaus P; Desch S; de Waha S; Gutberlet M; Schuler G; Thiele H
    Am J Cardiol; 2014 Aug; 114(4):503-9. PubMed ID: 24994545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: comparison with cardiovascular magnetic resonance.
    Porto I; Hamilton-Craig C; De Maria GL; Vergallo R; Cautilli G; Galiuto L; Burzotta F; Leone AM; Niccoli G; Natale L; Bonomo L; Crea F
    Am Heart J; 2011 Aug; 162(2):372-381.e2. PubMed ID: 21835300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
    Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grade 3 ischemia on the admission electrocardiogram is associated with severe microvascular injury on cardiac magnetic resonance imaging after ST elevation myocardial infarction.
    Weaver JC; Rees D; Prasan AM; Ramsay DD; Binnekamp MF; McCrohon JA
    J Electrocardiol; 2011; 44(1):49-57. PubMed ID: 21168001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognostic value of a comprehensive assessment of cardiac magnetic resonance indexes after an ST-segment elevation myocardial infarction.
    Merlos P; López-Lereu MP; Monmeneu JV; Sanchis J; Núñez J; Bonanad C; Valero E; Miñana G; Chaustre F; Gómez C; Oltra R; Palacios L; Bosch MJ; Navarro V; Llácer A; Chorro FJ; Bodí V
    Rev Esp Cardiol (Engl Ed); 2013 Aug; 66(8):613-22. PubMed ID: 24776329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study.
    Lønborg JT; Engstrøm T; Møller JE; Ahtarovski KA; Kelbæk H; Holmvang L; Jørgensen E; Helqvist S; Saunamäki K; Søholm H; Andersen M; Mathiasen AB; Kühl JT; Clemmensen P; Køber L; Vejlstrup N
    Eur Heart J Cardiovasc Imaging; 2013 Feb; 14(2):118-27. PubMed ID: 22696494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity troponin T predicts infarct scar characteristics and adverse left ventricular function by cardiac magnetic resonance imaging early after reperfused acute myocardial infarction.
    Nguyen TL; Phan JA; Hee L; Moses DA; Otton J; Terreblanche OD; Xiong J; Premawardhana U; Rajaratnam R; Juergens CP; Dimitri HR; French JK; Richards DA; Thomas L
    Am Heart J; 2015 Oct; 170(4):715-725.e2. PubMed ID: 26386795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of functional recovery by cardiac magnetic resonance feature tracking imaging in first time ST-elevation myocardial infarction. Comparison to infarct size and transmurality by late gadolinium enhancement.
    Buss SJ; Krautz B; Hofmann N; Sander Y; Rust L; Giusca S; Galuschky C; Seitz S; Giannitsis E; Pleger S; Raake P; Most P; Katus HA; Korosoglou G
    Int J Cardiol; 2015 Mar; 183():162-70. PubMed ID: 25675901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QRS distortion in pre-reperfusion electrocardiogram is a bedside predictor of large myocardium at risk and infarct size (a METOCARD-CNIC trial substudy).
    Valle-Caballero MJ; Fernández-Jiménez R; Díaz-Munoz R; Mateos A; Rodríguez-Álvarez M; Iglesias-Vázquez JA; Saborido C; Navarro C; Dominguez ML; Gorjón L; Fontoira JC; Fuster V; García-Rubira JC; Ibanez B
    Int J Cardiol; 2016 Jan; 202():666-73. PubMed ID: 26453814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.